INnate Implant: payments to doctors
Payments that named INnate Implant as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $801K
- Providers
- 1,056
- Transactions
- 2,543
- Average per transaction
- $315
The per-transaction average — $315 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,056 providers the average total is $759, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Acumed LLC | $713,297 | 89.0% |
| Exsomed Corporation | $87,753 | 11.0% |